Michael Uhlin

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2025;14(3):e70027
γδ T cell characterisation in the long term after haematopoietic stem cell transplantation and its impact on CMV control and cGVHD severity
Alagrafi F; Stikvoort A; Gaballa A; Solders M; Ringden O; Poiret T; Arruda LCM; Uhlin M
Article: ONCOIMMUNOLOGY. 2024;13(1):2379063
Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells
Al Agrafi F; Gaballa A; Hahn P; Arruda LCM; Jaramillo AC; Witsen M; Lehmann S; Onfelt B; Uhlin M; Stikvoort A
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2024;22(1):250
Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
Saffarzadeh N; Foord E; O'Leary E; Mahmoun R; Hansen TB; Levitsky V; Poiret T; Uhlin M
Article: JOURNAL OF IMMUNOLOGY. 2024;212(5):868-880
KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity
Leijonhufvud C; Sanz-Ortega L; Schlums H; Gaballa A; Andersson A; Eriksson C; Segerberg F; Uhlin M; Bryceson YT; Carlsten M
Article: BLOOD TRANSFUSION. 2024;22(2):130-139
Pathogen reduced red blood cells as an alternative to irradiated and washed components with potential for up to 42 days storage
Larsson L; Ohlsson S; Andersson TN; Watz E; Larsson S; Sandgren P; Uhlin M
Article: SCIENTIFIC REPORTS. 2024;14(1):1291
Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma
Sawaisorn P; Gaballa A; Saimuang K; Leepiyasakulchai C; Lertjuthaporn S; Hongeng S; Uhlin M; Jangpatarapongsa K
Article: NATURE COMMUNICATIONS. 2023;14(1):6035
Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
Sandoz PA; Kuhnigk K; Szabo EK; Thunberg S; Erikson E; Sandstroem N; Verron Q; Brech A; Watzl C; Wagner AK; Alici E; Malmberg K-J; Uhlin M; Oenfelt B
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(17):13097
Cryopreserved Platelets in a Non-Toxic DMSO-Free Solution Maintain Hemostatic Function In Vitro
Ehn K; Wikman A; Uhlin M; Sandgren P
Article: BLOOD TRANSFUSION. 2023;21(2):137-145
Cryopreserved platelets and amotosalen-treated plasma in an experimental clot formation set-up
Sandgren P; Ehn K; Larsson L; Uhlin M; Wikman A
Article: HAEMATOLOGICA. 2022;107(8):1786-1795
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo
Arruda LCM; Stikvoort A; Lambert M; Jin L; Rivera LS; Alves RMP; de Moura TR; Mim C; Lehmann S; Axelsson-Robertson R; Dick JE; Mattsson J; Onfelt B; Carlsten M; Uhlin M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(5):e13151
SARS-CoV-2 (COVID-19)-specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observation
Arruda LCM; Gaballa A; Rodrigues RDS; Makower B; Uhlin M
Article: VOX SANGUINIS. 2022;117(2):193-200
DEHT is a suitable plasticizer option for phthalate-free storage of irradiated red blood cells
Larsson L; Ohlsson S; Derving J; Diedrich B; Sandgren P; Larsson S; Uhlin M
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:954716
T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia
Soderstrom A; Vonlanthen S; Jonsson-Videsater K; Mielke S; Lindahl H; Torlen J; Uhlin M
Article: TRANSFUSION. 2021;61(2):546-556
Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols
Tynngard N; Bell A; Gryfelt G; Cvetkovic S; Wikman A; Uhlin M; Sandgren P
Article: SCIENCE TRANSLATIONAL MEDICINE. 2021;13(577):eabb0192
Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer
Foord E; Arruda LCM; Gaballa A; Klynning C; Uhlin M
Article: VOX SANGUINIS. 2021;116(1):60-70
Non-phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags
Larsson L; Sandgren P; Ohlsson S; Derving J; Friis-Christensen T; Daggert F; Frizi N; Reichenberg S; Chatellier S; Diedrich B; Antovic J; Larsson S; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2020;2020:7375947-12
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins
Foord E; Klynning C; Schoutrop E; Forster JM; Krieg J; Mortberg A; Mueller MR; Herzog C; Schiegg D; Villemagne D; Fiedler U; Snell D; Kebble B; Mattsson J; Levitsky V; Uhlin M
Article: SCIENCE IMMUNOLOGY. 2020;5(49):eaba7918
TOX is expressed by exhausted and polyfunctional human effector memory CD8⁺ T cells
Sekine T; Perez-Potti A; Son N; Gorin J-B; Wu VH; Gostick E; Llewellyn-Lacey S; Hammer Q; Falck-Jones S; Vangeti S; Yu M; Smed-Sorensen A; Gaballa A; Uhlin M; Sandberg JK; Brander C; Nowak P; Goepfert PA; Price DA; Betts MR; Buggert M
Article: BLOOD TRANSFUSION. 2020;18(3):191-199
Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light
Tynngard N; Wikman A; Uhlin M; Sandgren P
Article: STEM CELLS INTERNATIONAL. 2019;2019:6348060-13
CD8⁺γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response
Gaballa A; Arruda LCM; Radestad E; Uhlin M
Article: VOX SANGUINIS. 2019;114(7):769-777
Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation
Berglund S; Watz E; Remberger M; Legert KG; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Article: VOX SANGUINIS. 2019;114(7):711-720
A novel protocol for cryopreservation of paediatric red blood cell units allows increased availability of rare blood types
Larsson L; Larsson S; Derving J; Watz E; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2019;54(10):1562-1574
T-cell frequencies of CD8⁺ γδ and CD27⁺ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation
Gaballa A; Stikvoort A; Onfelt B; Mattsson J; Sundin M; Watz E; Uhlin M
Article: CLINICAL TRANSPLANTATION. 2019;33(6):e13537
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(6):1260-1268
Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Torlen J; Gaballa A; Remberger M; Mork L-M; Sundberg B; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY. 2019;202(6):1859-1870
Graft γδ TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution
Arruda LCM; Gaballa A; Uhlin M
Article: ONCOIMMUNOLOGY. 2019;8(2):e1535730
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
Radestad E; Klynning C; Stikvoort A; Mogensen O; Nava S; Magalhaes I; Uhlin M
Article: CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;44(1):84-91
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
Afram G; Watz E; Remberger M; Nygell UA; Sundin M; Hagglund H; Mattsson J; Uhlin M
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189
Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Radestad E; Sundin M; Torlen J; Thunberg S; Onfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: CELL TRANSPLANTATION. 2018;27(11):1692-1704
Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade
Watanabe M; Kumagai-Braesch M; Yao M; Thunberg S; Berglund D; Sellberg F; Jorns C; Enoksson SL; Henriksson J; Lundgren T; Uhlin M; Berglund E; Ericzon B-G
Article: TRANSFUSION. 2018;58(11):2657-2668
Cryopreservation of buffy coat-derived platelet concentrates photochemically treated with amotosalen and UVA light
Meinke S; Wikman A; Gryfelt G; Hultenby K; Uhlin M; Hoeglund P; Sandgren P
Article: VOX SANGUINIS. 2018;113(7):611-621
Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained invitro quality over 7-day storage
Ohlsson S; Diedrich B; Uhlin M; Sandgren P
Article: CYTOTHERAPY. 2018;20(7):941-951
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells
Alnabhan R; Gaballa A; Mork L-M; Mattsson J; Uhlin M; Magalhaes I
Article: TRANSFUSION. 2018;58(6):1442-1451
Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors
Wang T; Remberger M; Nygell UA; Sundin M; Bjorklund A; Mattsson J; Uhlin M; Watz E
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(3):467-477
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition
Stikvoort A; Gaballa A; Solders M; Nederlof I; Onfelt B; Sundberg B; Remberger M; Sundin M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOTHERAPY. 2018;41(2):73-83
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN- Production Profile
Magalhaes I; Kalland I; Kochenderfer JN; Osterborg A; Uhlin M; Mattsson J
Article: FRONTIERS IN ONCOLOGY. 2018;8:407
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
Nair D; Radestad E; Khalkar P; Diaz-Argelich N; Schroder A; Klynning C; Ungerstedt J; Uhlin M; Fernandes AP
Article: STEM CELLS INTERNATIONAL. 2018;2018:8529104-15
Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility
Berglund S; Gaballa A; Sawaisorn P; Sundberg B; Uhlin M
Article: ONCOTARGET. 2017;8(36):60257-60269
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
Radestad E; Egevad L; Jorns C; Mattsson J; Sundberg B; Nava S; Ericzon B-G; Henningsohn L; Levitsky V; Uhlin M
Article: CLINICAL TRANSPLANTATION. 2017;31(8)
No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies
Magalhaes I; Uhlin M; Schaffer M; Sundin M; Hauzenberger D; Remberger M; Mattsson J
Article: VOX SANGUINIS. 2017;112(5):459-468
Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation
Nilsson J; Granrot I; Mattsson J; Omazic B; Uhlin M; Thunberg S
Article: NATURE MEDICINE. 2017;23(2):256-263
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CBJ; Heshmati Y; Hagenkort A; Kutzner J; Paget BDG; Calderon-Montano JM; Loseva O; Jemth A-S; Bulli L; Axelsson H; Tesi B; Valerie NCK; Hoglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grander D; Lundback T; Kogner P; Henter J-I; Helleday T; Schaller T
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A; Chen Y; Radestad E; Torlen J; Lakshmikanth T; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: ONCOTARGET. 2016;7(17):23581-23593
Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes
Norstrom MM; Radestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
Article: FRONTIERS IN IMMUNOLOGY. 2016;7:119
Microchip screening Platform for single cell assessment of NK cell cytotoxicity
Guldevall K; Brandt L; Forslund E; Olofsson K; Frisk TW; Olofsson PE; Gustafsson K; Manneberg O; Vanherberghen B; Brismar H; Karre K; Uhlin M; Onfelt B
Article: PLOS ONE. 2016;11(5):e0154737
Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
Stikvoort A; Sundin M; Uzunel M; Gertow J; Sundberg B; Schaffer M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2016;2016:5601204-11
Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
Article: TRANSFUSION. 2015;55(10):2339-2350
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(5):889-893
Effect of Total Nucleated and CD34⁺ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Remberger M; Torlen J; Ringden E; Engstrom M; Watz E; Uhlin M; Mattsson J
Article: FRONTIERS IN IMMUNOLOGY. 2015;6:196
Single-cell characterization of in vitro migration and interaction dynamics of T cells expanded with IL-2 and IL-7
Tauriainen J; Gustafsson K; Gothlin M; Gertow J; Buggert M; Frisk TW; Karlsson AC; Uhlin M; Onfelt B
Article: CYTOTHERAPY. 2014;16(11):1528-1536
Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation
Berglund S; Gertow J; Uhlin M; Mattsson J
Article: PROSTATE. 2014;74(14):1391-1399
Novel Method to Characterize Immune Cells From Human Prostate Tissue
Norstrom MM; Radestad E; Stikvoort A; Egevad L; Bergqvist M; Henningsohn L; Mattsson J; Levitsky V; Uhlin M
Article: STEM CELLS AND DEVELOPMENT. 2014;23(14):1559-1567
T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
Article: TRANSPLANT INFECTIOUS DISEASE. 2014;16(2):203-212
Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation
Wikell H; Ponandai-Srinivasan S; Mattsson J; Gertow J; Uhlin M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):264-271
Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
Watz E; Remberger M; Ringden E; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Article: HAEMATOLOGICA. 2014;99(2):346-352
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2014;2014:578741-14
Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors
Radestad E; Wikell H; Engstrom M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOTHERAPY. 2013;36(8):432-441
Cord Blood T Cells Cultured With IL-7 in Addition to IL-2 Exhibit a Higher Degree of Polyfunctionality and Superior Proliferation Potential
Berglund S; Gertow J; Magalhaes I; Mattsson J; Uhlin M
Article: CLINICAL TRANSPLANTATION. 2013;27(4):E368-E374
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
Remberger M; Ringden O; Hagglund H; Svahn B-M; Ljungman P; Uhlin M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(5):838-844
Chimerism Patterns of Long-Term Stable Mixed Chimeras Posthematopoietic Stem Cell Transplantation in Patients with Nonmalignant Diseases: Follow-Up of Long-Term Stable Mixed Chimerism Patients
Stikvoort A; Gertow J; Sundin M; Remberger M; Mattsson J; Uhlin M
Article: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2013;9(4):307-317
Systems level immune response analysis and personalized medicine
Brodin P; Valentini D; Uhlin M; Mattsson J; Zumla A; Maeurer MJ
Article: CHIMERISM. 2013;4(1):34-35
Chimerism and use of mesenchymal stem cells in umbilical cord blood transplantation.
Berglund S; Uhlin M; Mattsson J
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2012;42(11):2990-3000
Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics
Allerbring EB; Duru AD; Uchtenhagen H; Madhurantakam C; Tomek MB; Grimm S; Mazumdar PA; Friemann R; Uhlin M; Sandalova T; Nygren P-A; Achour A
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: TRANSPLANT IMMUNOLOGY. 2012;27(1):59-62
Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation
Remberger M; Persson M; Mattsson J; Gustafsson B; Uhlin M
Article: STEM CELLS AND DEVELOPMENT. 2012;21(9):1409-1417
Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation
Uhlin M; Sairafi D; Berglund S; Thunberg S; Gertow J; Ringden O; Uzunel M; Remberger M; Mattsson J
Article: JOURNAL OF INFECTIOUS DISEASES. 2012;205:S325-S334
Adjunct Immunotherapies for Tuberculosis
Uhlin M; Andersson J; Zumla A; Maeurer M
Article: CLINICAL IMMUNOLOGY. 2012;143(2):134-144
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation
Gertow J; Berglund S; Okas M; Karre K; Remberger M; Mattsson J; Uhlin M
Article: CLINICAL IMMUNOLOGY. 2012;142(3):343-350
Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival
Sairafi D; Mattsson J; Uhlin M; Uzunel M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: TRANSPLANT IMMUNOLOGY. 2011;25(2-3):153-158
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation
Nordlander A; Uhlin M; Ringden O; Kumlien G; Hauzenberger D; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2010;16(12):1728-1737
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
Sairafi D; Remberger M; Uhlin M; Ljungman P; Ringden O; Mattsson J
Article: CHIMERISM. 2010;1(2):64-65
Stable mixed double donor chimerism: Absence of war doesn't necessarily mean peace.
Gertow J; Mattsson J J; Uhlin M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;162(1):146-155
Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation
Gertow J; Berglund S; Okas M; Uzunel M; Berg L; Karre K; Mattsson J; Uhlin M
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2010;59(3):473-477
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Uhlin M; Okas M; Gertow J; Uzunel M; Brismar TB; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2010;45(2):235-238
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Mattsson J; Nordlander A; Remberger M; Uhlin M; Holgersson J; Ringden O; Hauzenberger D
Article: JOURNAL OF IMMUNOTHERAPY. 2010;33(1):96-105
Clinical Expansion of Cord Blood-derived T Cells for Use as Donor Lymphocyte Infusion After Cord Blood Transplantation
Okas M; Gertow J; Uzunel M; Karlsson H; Westgren M; Karre K; Ringden O; Mattsson J; Uhlin M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2009;90(4):526-531
Stable mixed donor-donor chimerism after double cord blood transplantation
Berglund S; Okas M; Gertow J; Uhlin M; Mattsson J
Article: TRANSPLANTATION. 2009;87(4):467-472
Increased Frequency and Responsiveness of PSA-Specific T Cells After Allogeneic Hematopoetic Stem-Cell Transplantation
Uhlin M; Okas M; Karlsson H; Gertow J; Henningsohn L; Ringden O; Karre K; Levitsky V; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2008;42(10):643-648
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor
Ringden O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Article: JOURNAL OF IMMUNOTHERAPY. 2008;31(3):283-293
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes
Markasz L; Skribek H; Uhlin M; Otvos R; Flaberg E; Eksborg S; Olah E; Stuber G; Szekely L
Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2007;82(4):887-893
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
Rasmusson I; Uhlin M; Le Blanc K; Levitsky V
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2005;35(10):2929-2939
Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes
Uhlin M; Sandalova E; Masucci MG; Levitsky V
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005;102(26):9264-9269
Regulation of lck degradation and refractory state in CD81 cytotoxic T lymphocytes
Uhlin M; Masucci MG; Levitsky V
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2003;57(2):99-106
Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes
Uhlin M; Masucci MG; Levitsky V
Article: HUMAN IMMUNOLOGY. 2002;63(10):821-833
Tetramer binding and secretion of interferon-γ in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation
Wei CH; Uhlin M; Masucci MG; Levitsky V
Visa fler

Anställningar

Adjungerad Professor, Medicin, Huddinge, Karolinska Institutet, 2024-2028

Examina och utbildning

Docent, Immunologi, Karolinska Institutet, 2012
MEDICINE DOKTORSEXAMEN, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2006

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI